Logos Global Management »

Erasca shares owned by Logos Global Management

Quarter-by-quarter ownership of Erasca (ERAS) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Erasca

Tip: Access up to 7 years of quarterly data

All positions including Erasca held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Erasca by Logos Global Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $14M 5.9M 2.36

More positions owned by Logos Global Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Sarepta Therapeutics (SRPT)
Sarepta Therapeutics Call Option (SRPT)
Apellis Pharmaceuticals Call Option (APLS)
Apellis Pharmaceuticals (APLS)
Structure Therapeutics Sponsored Ads Call Option (GPCR)
Structure Therapeutics Sponsored Ads (GPCR)
Ideaya Biosciences (IDYA)
Ideaya Biosciences (IDYA)
Argenx Se Sponsored Adr (ARGX)
Argenx Se Sponsored Adr (ARGX)
Merus N V (MRUS)
Merus N V (MRUS)
Revolution Medicines (RVMD)

View all positions for Logos Global Management

Top funds holding Erasca

VR Adviser
Frazier Life Sciences Management
Suvretta Capital Management
Arch Venture Corp
BlackRock
Vanguard Group
Artal Group
Henderson Group
Silverarc Capital Management
T. Rowe Price Investment Management
Paradigm Biocapital Advisors
Logos Global Management
5AM Venture Management
Partner Fund Management
Balyasny Asset Management

View all funds holding Erasca